Navigation Links
WellPoint Congratulates President-Elect Barack Obama
Date:11/5/2008

holders will be the key to positive change, and we stand ready to work with President-Elect Obama to advance health care for all Americans.

About WellPoint, Inc.

WellPoint, Inc. is the largest publicly traded commercial health benefits company in terms of membership in the United States. WellPoint, Inc. is an independent licensee of the Blue Cross Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield in 10 New York City metropolitan counties and as Blue Cross, Blue Shield or Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com.


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. WellPoint Announces Appearances at Upcoming Conferences
2. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
3. WellPoint Announces Realignment of Core Businesses; Names New Executives
4. Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association
5. WellPoint NextRx Receives National Leadership Award for Innovative Web Tool
6. WellPoint Reports Third Quarter 2007 Results
7. WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors
8. WellPoint Provides Support and Resources to Most Vulnerable California Residents
9. WellPoint Announces Appointment of John Cannon III as Executive Vice President & General Counsel
10. WellPoint Highlights 2007 Accomplishments and Strong 2008 Outlook at Annual Investor Meeting
11. WellPoint Announces Appointment of John Langenus as President of Anthem National Accounts
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 2Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 3Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 4Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 5Confusion Over Homeopathic Medicines in Alexa Ray Joel's Hospitalization Clarified by the American Association of Homeopathic Pharmacists (AAHP) 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Platelet Rich Plasma Therapy 28PRP 29 Accelerates Healing of Joint Injuries Osteoarthritis Pain 49564 1Platelet Rich Plasma Therapy 28PRP 29 Accelerates Healing of Joint Injuries Osteoarthritis Pain 49564 2Platelet Rich Plasma Therapy 28PRP 29 Accelerates Healing of Joint Injuries Osteoarthritis Pain 49564 3Platelet Rich Plasma Therapy 28PRP 29 Accelerates Healing of Joint Injuries Osteoarthritis Pain 49564 4Responses After Completion of Therapy Increase Pixantrone Complete Remission 28CR 29 Unconfirmed Complete Remission 28CRu 29 Rate to 24 25 and Overa 4621 1Responses After Completion of Therapy Increase Pixantrone Complete Remission 28CR 29 Unconfirmed Complete Remission 28CRu 29 Rate to 24 25 and Overa 4621 2Responses After Completion of Therapy Increase Pixantrone Complete Remission 28CR 29 Unconfirmed Complete Remission 28CRu 29 Rate to 24 25 and Overa 4621 3Responses After Completion of Therapy Increase Pixantrone Complete Remission 28CR 29 Unconfirmed Complete Remission 28CRu 29 Rate to 24 25 and Overa 4621 4Responses After Completion of Therapy Increase Pixantrone Complete Remission 28CR 29 Unconfirmed Complete Remission 28CRu 29 Rate to 24 25 and Overa 4621 5Responses After Completion of Therapy Increase Pixantrone Complete Remission 28CR 29 Unconfirmed Complete Remission 28CRu 29 Rate to 24 25 and Overa 4621 6Study finds cancer is the second most frequent cause of death in individuals with schizophrenia 49558 1Study finds cancer is the second most frequent cause of death in individuals with schizophrenia 49558 2